These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32273759)

  • 1. Long Non-Coding RNA
    Luo Y; Liu F; Yan C; Qu W; Zhu L; Guo Z; Zhou F; Zhang W
    Cancer Manag Res; 2020; 12():2195-2207. PubMed ID: 32273759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-377 functions as a tumor suppressor in human clear cell renal cell carcinoma by targeting ETS1.
    Wang R; Ma Y; Yu D; Zhao J; Ma P
    Biomed Pharmacother; 2015 Mar; 70():64-71. PubMed ID: 25776481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis.
    Wang X; Ou H; Zhou L; Liu H; Liu X; Zhang H
    Exp Ther Med; 2021 Jul; 22(1):754. PubMed ID: 34035851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Noncoding RNA LINC01426 Sequesters microRNA-519d-5p to Promote Non-Small Cell Lung Cancer Progression by Increasing ETS1 Expression.
    Dai J; Wang B; Zhao Y; Zuo X; Cui H; Chen X; Liu X
    Cancer Manag Res; 2020; 12():12697-12708. PubMed ID: 33335425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA CASC19 promotes the proliferation, migration and invasion of non-small cell lung carcinoma via regulating miRNA-130b-3p.
    Qu CX; Shi XC; Zai LQ; Bi H; Yang Q
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):247-255. PubMed ID: 31389608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ETS Proto-Oncogene 1-activated muskelin 1 antisense RNA drives the malignant progression of hepatocellular carcinoma by targeting miR-22-3p to upregulate ETS Proto-Oncogene 1.
    Pan G; Zhang J; You F; Cui T; Luo P; Wang S; Li X; Yuan Q
    Bioengineered; 2022 Jan; 13(1):1346-1358. PubMed ID: 34983308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LINC00511 promotes the malignant phenotype of clear cell renal cell carcinoma by sponging microRNA-625 and thereby increasing cyclin D1 expression.
    Deng H; Huang C; Wang Y; Jiang H; Peng S; Zhao X
    Aging (Albany NY); 2019 Aug; 11(16):5975-5991. PubMed ID: 31434797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of SBF2-AS1 functions as a tumor suppressor in clear cell renal cell carcinoma by inhibiting miR-338-3p-targeted ETS1.
    Yang X; Zhang Y; Fan H
    Cancer Gene Ther; 2021 Aug; 28(7-8):813-827. PubMed ID: 32719443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA HCP5 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-140-5p/IGF1R pathway.
    Zhang YJ; Lu C
    Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):2965-2975. PubMed ID: 32271414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
    Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
    Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long non-coding RNA CASC19 facilitates non-small cell lung cancer cell proliferation and metastasis by targeting the miR-301b-3p/LDLR axis.
    Wang L; Lin C; Sun N; Wang Q; Ding X; Sun Y
    J Gene Med; 2020 Dec; 22(12):e3254. PubMed ID: 32677267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long Non-Coding RNA
    Cancer Manag Res; 2022; 14():2305-2306. PubMed ID: 35958952
    [No Abstract]   [Full Text] [Related]  

  • 14. Long Non-Coding RNA TTN-AS1 Serves as a Competing Endogenous RNA of miR-195 to Facilitate Clear Cell Renal Cell Carcinoma Progression.
    Lin K; Chen H; Su C; Zhu H; Lai C; Shi Y
    Cancer Manag Res; 2020; 12():3091-3097. PubMed ID: 32440207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Non-Coding RNA
    Cancer Manag Res; 2023; 15():683-684. PubMed ID: 37465079
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA CCAT2 promotes cell proliferation and invasion through regulating Wnt/β-catenin signaling pathway in clear cell renal cell carcinoma.
    Huang JL; Liao Y; Qiu MX; Li J; An Y
    Tumour Biol; 2017 Jul; 39(7):1010428317711314. PubMed ID: 28718366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long Non-Coding RNA LINC00491 Contributes to the Malignancy of Non-Small-Cell Lung Cancer via Competitively Binding to microRNA-324-5p and Thereby Increasing Specificity Protein 1 Expression.
    Zhang X; Zhao X; Wang Y; Xing L
    Cancer Manag Res; 2020; 12():6779-6793. PubMed ID: 32821159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA CASC19: a novel oncogene involved in human cancer.
    Wang S; Qiao C; Fang R; Yang S; Zhao G; Liu S; Li P
    Clin Transl Oncol; 2023 Oct; 25(10):2841-2851. PubMed ID: 37029242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non‑coding RNA CASC19 promotes glioma progression by modulating the miR‑454‑3p/RAB5A axis and is associated with unfavorable MRI features.
    Wu YJ; Yang QS; Chen H; Wang JT; Wang WB; Zhou L
    Oncol Rep; 2021 Feb; 45(2):728-737. PubMed ID: 33416169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LncRNA CASC19 contributed to the progression of pancreatic cancer through modulating miR-148b/E2F7 axis.
    Lu T; Wei GH; Wang J; Shen J
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10462-10471. PubMed ID: 33155202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.